Skip to main content
Fig. 10 | Journal of Nanobiotechnology

Fig. 10

From: Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies

Fig. 10

Copyright © 2020 Springer

In vivo antitumor activity by PTX-Rh2-liposome. A Fabrication and application of PTX-Rh2-liposome. a The similar structure of ginsenoside Rh2 and cholesterol. b The properties including membrane stability, stealth, GLUT targeting to tumors, as well as TME remodeling of ginsenoside Rh2. B PTX-Rh2-liposome induced apoptosis of tumor cells. C The increased CD8+ T cells and decreased CD4+ T cells induced by PTX-Rh2-liposome. Reprinted with the permission from Ref [25].

Back to article page